Par Files Declaratory Suit Over Diabetes Generic
Novartis AG and Japanese drugmaker Ajinomoto Co. Inc. have been hit with a declaratory action by Par Pharmaceutical Inc., which is looking to market a generic version of the companies' type...To view the full article, register now.
Already a subscriber? Click here to view full article